AnalystsCory KasimovCory Kasimov's Stock Forecasts
AnalystsCory Kasimov
Analyst Ranking
Top 22%
#1045 out of 4861 analysts
Average Return
+5.44%
Win Rate
45%19 out of 42
Risk vs Reward
Poor
Good
Cory Kasimov's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Bluebird Bio IncBLUE | +369.12% | $733.20 | $3,439.60 | 2014-06-18 - 2015-06-18 | Strong Buy |
Gilead Sciences IncGILD | +90.55% | $32.90 | $62.69 | 2012-09-16 - 2013-09-17 | Strong Buy |
Karuna Therapeutics IncKRTX | +83.52% | $122.33 | $224.50 | 2021-09-29 - 2022-09-29 | Strong Buy |
Puma Biotechnology IncPBYI | +64.47% | $20.07 | $7.13 | 2018-11-01 - 2019-11-01 | Strong Sell |
Puma Biotechnology IncPBYI | +64.47% | $20.07 | $7.13 | 2018-11-01 - 2019-11-01 | Strong Sell |
Cory Kasimov Analyst Color
Get additional color on Cory Kasimov's coverage of popular stocks
Cory Kasimov's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Summit Therapeutics IncSMMT | 1 | Buy | $30.00 | +21.90% | Initiates Coverage On | a month ago |
Springworks Therapeutics IncSWTX | 2 | Buy | $65.00 | +71.41% | Maintains | 2 months ago |
Moderna IncMRNA | 4 | Hold | $50.00 | +102.31% | Maintains | 3 months ago |
Bridgebio Pharma IncBBIO | 3 | Buy | $50.00 | +47.62% | Maintains | 4 months ago |
Edgewise Therapeutics IncEWTX | 2 | Buy | $50.00 | +271.75% | Maintains | 4 months ago |
Biontech SeBNTX | 3 | Buy | $125.00 | +26.57% | Upgrades | 5 months ago |
Biomarin Pharmaceutical IncBMRN | 4 | Buy | $105.00 | +77.45% | Maintains | 6 months ago |
Regeneron Pharmaceuticals IncREGN | 4 | Buy | $1,175.00 | +108.64% | Maintains | 6 months ago |
Arcellx IncACLX | 1 | Buy | $85.00 | +37.05% | Initiates Coverage On | a year ago |
Neurocrine Biosciences IncNBIX | 1 | Buy | $175.00 | +72.62% | Initiates Coverage On | a year ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Strong Buy | $88.00 | N/A | Maintains | a year ago |
Karuna Therapeutics IncKRTX | 2 | Strong Buy | $250.00 | N/A | Maintains | 2 years ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 3 years ago |
Biogen IncBIIB | 2 | Hold | $276.00 | N/A | Maintains | 3 years ago |
Sana Biotechnology IncSANA | 1 | Hold | $35.00 | N/A | Initiates Coverage On | 4 years ago |
Bluebird Bio IncBLUE | 5 | Hold | $780.00 | N/A | Downgrades | 4 years ago |
Incyte CorpINCY | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Strong Buy | $163.00 | N/A | Maintains | 5 years ago |
Alkermes PLCALKS | 2 | Hold | $21.00 | N/A | Downgrades | 5 years ago |
Jounce Therapeutics IncJNCE | 4 | Strong Sell | N/A | N/A | Downgrades | 6 years ago |
Puma Biotechnology IncPBYI | 4 | Strong Sell | $23.00 | N/A | Maintains | 6 years ago |
Clovis Oncology IncCLVSQ | 5 | Hold | $16.00 | N/A | Downgrades | 6 years ago |
Amgen IncAMGN | 2 | Hold | $192.00 | N/A | Maintains | 7 years ago |
Spark Therapeutics IncONCE | 3 | Hold | $63.00 | N/A | Maintains | 7 years ago |
Celgene CorpCELG | 1 | Strong Buy | $110.00 | N/A | Reinstates | 7 years ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Strong Sell | $10.00 | N/A | Maintains | 7 years ago |
Dynavax Technologies CorpDVAX | 1 | Hold | $250.00 | N/A | Maintains | 7 years ago |
Atyr Pharma IncATYR | 2 | Strong Buy | $140.00 | N/A | Maintains | 9 years ago |
Gilead Sciences IncGILD | 1 | Strong Buy | $37.50 | N/A | Maintains | 13 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.